本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Biodesix, Inc.

6.58
+0.58009.67%
成交量:11.53萬
成交額:72.92萬
市值:5,132.40萬
市盈率:-1.18
高:6.67
開:5.95
低:5.91
收:6.00
52周最高:34.40
52周最低:3.44
股本:780.00萬
流通股本:339.60萬
量比:0.41
換手率:3.39%
股息:- -
股息率:- -
每股收益(TTM):-5.5983
每股收益(LYR):-6.6216
淨資產收益率:-219.68%
總資產收益率:-20.81%
市淨率:45.10
市盈率(LYR):-0.99

資料載入中...

2024/11/08

SEC問詢函

Form CORRESP - Correspondence
2024/11/08

SEC問詢函

Form CORRESP - Correspondence
2024/11/01

重要事件披露

Form 8-K - Current report
2024/11/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/06/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/01

SEC問詢函

Form CORRESP - Correspondence
2024/05/25

SEC問詢函

Form CORRESP - Correspondence
2024/05/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]